First of its kind cancer stem cell research unlocks clues to
Researchers at Trinity College Dublin have made exciting new findings that could offer a means of fighting resistance to treatment for people with oesophageal cancer. Resistance to radiotherapy is a major stumbling block in the treatment of this cancer.

For the first time, the research team led by Dr Stephen Maher, Ussher Assistant Professor in Translational Oncology at Trinity, have discovered that a molecule lost from cancer stem cells, called miR-17, is important in driving oesophageal tumour resistance to radiotherapy.

Read more at: https://medicalxpress.com/news/2017-01-kind-cancer-stem-cell-clues.html#jCp
Like
Comment
Share